All Roll Calls
Yes: 139 • No: 20
ArizonaHB 2082Fifty-seventh Legislature - Second Regular SessionHouseWALLET
childhood cancer research; commission
Sponsored By: Selina Bliss (Republican)
Signed by Governor
annual report (s)childhood cancer and rare childhood disease research commissionchildhood cancer and rare childhood disease research fund (s)childhood cancer researchcommissionconflict of interest (s)department of health services (dhs)dhs (see also: department of health services)membership (s)public health and safety - title 36reimbursement (s)
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Fee payers get first $32,000 refunded
The law requires the first $32,000 collected under the cited state law to go back to whoever paid the implementation fee. That is the total amount, not an amount promised to each payer. The law does not say how it is divided if several people or groups paid.
New grants for childhood disease research
The law creates a state fund for childhood cancer and rare childhood disease research. The fund receives money collected under state law, legislative appropriations, gifts, donations, and federal grants. It is continuously appropriated, does not lapse, and the director distributes its money each year. When appropriations or federal grants for this research reach at least $5 million, the director allocates fund money to Arizona nonprofit health care providers and research institutions conducting phase I trials. If additional appropriations or grants do not reach $5 million, money collected under the cited state law goes to qualifying Arizona nonprofits conducting clinical trials. Both paths allow collaboration with facilities outside Arizona. The commission sets trial criteria and reviews applications to help the director choose grants; recipients must use the money for the required research, even when combined with other funds. The fund may use no more than 10% of annual deposits for its administration. The director may use up to 4% of appropriated or grant money for administration, unless a federal grant contract says otherwise. The commission has at least seven members, holds open meetings with public testimony, and reports grant details each year by August 1, starting in 2027. Members serve five-year terms, receive no pay but may get expense reimbursement, and must step aside when they have a conflict.
Sponsors & Cosponsors
Sponsor
Selina Bliss
Republican • House
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
House vote • 6/2/2026
Final Reading: Passed
Yes: 46 • No: 11
House vote • 6/2/2026
Concurrence: Passed
Yes: 0 • No: 0
Senate vote • 5/18/2026
Third Reading: Passed
Yes: 23 • No: 0
Senate vote • 3/11/2026
Health and Human Services: DPA
Yes: 7 • No: 0
House vote • 2/25/2026
Third Reading: Passed
Yes: 44 • No: 9
House vote • 2/16/2026
Rules: C&P
Yes: 7 • No: 0
House vote • 1/22/2026
Health & Human Services: DP
Yes: 12 • No: 0
Actions Timeline
Signed by Governor
6/4/2026GovernorFinal Reading: Passed
6/2/2026HouseConcurrence: Passed
6/2/2026HouseThird Reading: Passed
5/18/2026SenateCommittee of the Whole: do pass amended
5/18/2026SenateRules: PFC
4/20/2026SenateHealth and Human Services: DPA
3/11/2026SenateSenate Second Reading
3/3/2026SenateSenate First Reading
3/2/2026SenateThird Reading: Passed
2/25/2026HouseCommittee of the Whole: do pass amended
2/24/2026HouseRules: C&P
2/16/2026HouseHealth & Human Services: DP
1/22/2026HouseHouse Second Reading
1/13/2026HouseHouse First Reading
1/12/2026House
Bill Text
Chaptered Version
House Engrossed Version (02/25/2026)
Introduced Version
Senate Engrossed Version (05/18/2026)